Maravai LifeSciences Inc... (MRVI)
2.31
0.07 (3.13%)
At close: Mar 25, 2025, 3:59 PM
2.31
0.36%
Pre-market: Mar 26, 2025, 07:08 AM EDT
3.13% (1D)
| Bid | 2.3 |
| Market Cap | 331.12M |
| Revenue (ttm) | 269.98M |
| Net Income (ttm) | -150.88M |
| EPS (ttm) | -1.05 |
| PE Ratio (ttm) | -2.2 |
| Forward PE | -84.15 |
| Analyst | Hold |
| Ask | 2.38 |
| Volume | 2,788,403 |
| Avg. Volume (20D) | 3,187,644 |
| Open | 2.25 |
| Previous Close | 2.24 |
| Day's Range | 2.25 - 2.37 |
| 52-Week Range | 2.07 - 11.55 |
| Beta | -0.00 |
About MRVI
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the productio...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 20, 2020
Employees 570
Stock Exchange NASDAQ
Ticker Symbol MRVI
Website https://www.maravai.com
Analyst Forecast
According to 10 analyst ratings, the average rating for MRVI stock is "Hold." The 12-month stock price forecast is $6.5, which is an increase of 182.00% from the latest price.
Stock ForecastsEarnings Surprise
Maravai LifeSciences has released their quartely earnings
on Mar 18, 2025:
Next Earnings Release
Maravai LifeSciences Inc. is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-5.81%
Maravai LifeSciences shares are trading lower afte...
Unlock content with
Pro Subscription
4 weeks ago
-21.7%
Maravai LifeSciences shares are trading lower after the company postponed its Q4 earnings release and call.
